54 Results for "

HLA-A*0201

" in MedChemExpress (MCE) Product Catalog:
Products (54)

54 Results for "HLA-A*0201" in MCE Product Catalog:

Cat. No.: HY-P0277
CAS No.: 168635-85-6
Synonyms: CEA peptide
Carcinoembryonic antigen peptide 1 (CEA peptide) is a 9-amino acid HLA-A0201-binding cytotoxic T lymphocyte (CTL) epitope peptide derived from carcinoembryonic antigen (CEA). The IC50 of Carcinoembryonic antigen peptide 1 binding to HLA-A0201 is 2 μM. Carcinoembryonic antigen peptide 1 binds to HLA-A0201 to form a peptide-MHC I complex, which is recognized by the T cell receptor (TCR) of CAP1-specific CD8 + CTLs, thereby inducing antigen-specific T cell activation, IFN-γ production, and CTL-mediated lysis of target cells. Carcinoembryonic antigen peptide 1 is used in research on CEA-specific CTL responses and colorectal cancer .
loading...
    loading...
Cat. No.: HY-P1780
CAS No.: 153045-21-7
Target:  

CMV

Research Areas:  

Infection

CEF20 is an HLA-A*0201-restricted epitope from cytomegalovirus pp65 (495-503).
loading...
    loading...
Cat. No.: HY-P1827
CAS No.: 219312-69-3
Target:  

Tyrosinase MHC

Research Areas:  

Cancer

mTRP-2 (180-188) is an MHC class I-restricted tumor-associated antigenic peptide derived from mouse tyrosinase-related protein 2 (TRP-2). mTRP-2 (180-188) binds to HLA-A*0201 with an ID50 of 36 nM. mTRP-2 (180-188) can be presented by H-2K b molecules and activate TRP-2-specific cytotoxic T lymphocytes (CTL). mTRP-2 (180-188) induces immune responses against B16 melanoma by promoting antigen-specific T cell proliferation, cytokine release, and CTL-mediated tumor cell killing. mTRP-2 (180-188) can be used in studies related to melanoma, glioma, and tumor immunology .
loading...
    loading...
Cat. No.: HY-P1780A
Target:  

CMV

Research Areas:  

Infection

CEF20 TFA is an HLA-A*0201-restricted epitope from cytomegalovirus pp65 (495-503).
loading...
    loading...
Cat. No.: HY-P11084
CAS No.: 256952-63-3
Target:  

MHC

Research Areas:  

Inflammation/Immunology Cancer

WT1 126-134 peptide is a Wilms' tumor oncogene protein (WT1) peptide (RMFPNAPYL). WT1 126-134 peptide is presented by HLA-A0201 and induces cytotoxic CD8 T cells capable of killing WT1+ positive tumor cells. WT1 126-134 can form stable complexes with the H-2Db (mouse) or HLA-A0201 (human) molecules. WT1 126-134 peptide/HLA-A0201 complex has an extremely high affinity (Kd = 0.2 nM) with the humanized monoclonal antibody (IgG1). WT1 126-134 peptide can be used as a vaccine for T cells or as a target for antibodies .
loading...
    loading...
Cat. No.: HY-P11379
CAS No.: 303068-29-3
Target:  

Survivin MHC

Research Areas:  

Inflammation/Immunology Cancer

ELTLGEFLKL is a survivin peptide. ELTLGEFLKL shows significant stabilization of HLA-A*0201. ELTLGEFLKL can be used in the research of tumor immunotherapy .
loading...
    loading...
Cat. No.: HY-P1757
CAS No.: 147468-65-3
Target:  

HIV

Research Areas:  

Infection

HIV p17 Gag (77-85) is an HLA-A*0201(A2)-restricted CTL epitope, used in the research of anti-HIV .
loading...
    loading...
Cat. No.: HY-P1881
CAS No.: 160040-04-0
Target:  

HPV

Research Areas:  

Cancer

HPV16-E711-20 epitope is a well-known HLA-A *0201-restricted human cytotoxic T lymphocyte (CTL) epitope of the HPV16 E7 protein that shows high-affinity binding to HLA-A2 in vitro. HPV16 CTL epitopes may be good candidates for the development of an effective peptide-based antitumor vaccine .
loading...
    loading...
Cat. No.: HY-P5478
CAS No.: 318273-25-5
Research Areas:  

Others

Influenza virus PA (46-54) is a biological active peptide. (HLA-A*0201 restricted epitope from influenza virus RNA polymerase subunit, PA (46-54).)
loading...
    loading...
Cat. No.: HY-P11434
CAS No.: 474885-03-5
Target:  

MHC

Research Areas:  

Cancer

Adipophilin-derived peptide is a peptide derived from Adipophilin. Adipophilin-derived peptide binds to HLA-A*0201. Adipophilin-derived peptide can be used in cancer research .
loading...
    loading...
Cat. No.: HY-P5471
CAS No.: 204060-45-7
Synonyms: [Leu27]-Melan-A, MART-1 (26-35)
Target:  

Inhibitory Antibodies

Research Areas:  

Others

Melan-A/MART-1 analog ([Leu27]-Melan-A, MART-1 (26-35)) is a biological active peptide. (This Melan-A (26-35) analog, Leu substituted for Ala at position 27, shows better HLA-A*0201 binding properties as well as better immunogenicity and antigenicity than the natural Melan-A (26-35).Pyroglutamyl (pGlu) peptides may spontaneously form when either Glutamine (Q) or Glutamic acid (E) is located at the sequence N-terminus. The conversion of Q or E to pGlu is a natural occurrence and in general it is believed that the hydrophobic γ-lactam ring of pGlu may play a role in peptide stability against gastrointestinal proteases. Pyroglutamyl peptides are therefore considered a normal subset of such peptides and are included as part of the peptide purity during HPLC analysis.)
loading...
    loading...
Cat. No.: HY-P4667
CAS No.: 204931-32-8
Target:  

Inhibitory Antibodies

Research Areas:  

Metabolic Disease

VLHDDLLEA is a peptide that can be isolated from the MHC complex HLA-A*0201 molecule. VLHDDLLEA can be recognized by HLA-A*0201-restricted cytotoxic T cells (CTLs). VLHDDLLEA can be used for research on graft versus host disease (GvHD) .
loading...
    loading...
Cat. No.: HY-P5503
CAS No.: 139079-41-7
Target:  

HIV

Research Areas:  

Others

Pol (476-484), HIV-1 RT Epitope is a biological active peptide. (This is a reverse transcriptase (RT) epitope (Pol residues 476-484). Within HIV-1 RT the peptide appears to be the dominant HLA A*0201-restricted epitope. Was used to investigate possible mechanisms behind HIV-1 escape from CTL. IV9 is the actual epitope processed and presented in HIV-1-infected cell lines.)
loading...
    loading...
Cat. No.: HY-P11084A
Target:  

MHC

Research Areas:  

Inflammation/Immunology Cancer

WT1 126-134 peptide acetate is a Wilms' tumor oncogene protein (WT1) peptide (RMFPNAPYL). WT1 126-134 peptide acetate is presented by HLA-A0201 and induces cytotoxic CD8 T cells capable of killing WT1+ positive tumor cells. WT1 126-134 can form stable complexes with the H-2Db (mouse) or HLA-A0201 (human) molecules. WT1 126-134 peptide acetate/HLA-A0201 complex has an extremely high affinity (Kd = 0.2 nM) with the humanized monoclonal antibody (IgG1). WT1 126-134 peptide acetate can be used as a vaccine for T cells or as a target for antibodies .
loading...
    loading...
Cat. No.: HY-P70392
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HLA-A*0201 GP100 complex
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P705310
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: HLA-A*0201; B2M; EW (QLQNPSYDK)
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P705316
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: HLA-A*0201; B2M; HPV (TIHDIILECV)
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P705317
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HLA-A*0201; B2M; hTERT (ILAKFLHWL)
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P705332
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: HLA-A*0201; B2M; PRAME (ALYVDSLFFL)
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P705334
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: HLA-A*0201; B2M; PSMA (MMNDQLMFL)
Species:  
Human
Source:  
HEK293
loading...
    loading...